Latest Research
All publications from the Cancer3.AI database, newest first.
A Misleading Cystic Brain Lesion: An Uncommon Presentation of Meningioma.
Singuepire A, et al
Researchers from Cureus journal report a rare case of cystic meningioma in a 40-year-old woman whose brain tumor was initially mistaken for a more common glial tumor based on imaging alone. The patient presented with seizures beginning during late pregnancy and the postpartum period, followed by headaches, urinary incontinence, and progressive neurological decline including right-sided weakness and psychomotor slowing. Brain imaging revealed a large cystic mass with an enhancing nodule in the left frontoparietal region causing significant brain shift, which closely resembled a glial neoplasm rather than a meningioma. Surgical removal of the entire tumor was performed, and laboratory analysis of the tissue confirmed the diagnosis of meningothelial meningioma with cystic features. The patient recovered well after surgery without new neurological complications. This case underscores the importance for clinicians to include cystic meningioma in the differential diagnosis of unusual cystic brain lesions, as prompt and correct identification leads to appropriate surgical treatment and favorable patient outcomes.
Cureus
Source →The Causal Role of Bile Acids in Cancers of the Digestive System.
Bernstein C, et al
A new literature review published in Biomedicines examines the causal role of bile acids in cancers throughout the entire digestive system, which collectively account for approximately 5 million new cases worldwide in 2022. Researchers found that bile acids contribute to cancer development through multiple mechanisms, including disruption of mitochondrial membranes in colon cells that releases DNA-damaging free radicals, alteration of the gut microbiome toward inflammation-promoting bacteria, and activation of the NF-kB signaling pathway that can switch on cancer-causing genes. Bile acid reflux was identified as a significant driver of esophageal adenocarcinoma, stomach cancer, and small intestine tumors, while constriction of the common bile duct can push bile acids back into the pancreas, liver, and biliary tract, promoting cancer in those organs as well. The findings suggest that bile acids are a likely major contributory cause of cancer across the entire gastrointestinal tract, pointing to dietary habits such as high-fat consumption as modifiable risk factors. For clinicians and patients, this comprehensive view opens avenues for prevention strategies targeting bile acid levels and composition, as well as new therapeutic targets for some of the world's most common and deadly cancers.
Biomedicines
Source →Development and validation of a nomogram for predicting progression from multidrug-resistant bacterial colonization to infection in lymphoma patients.
Ran X, et al
A new study published in Discover Oncology examined which clinical factors predict whether lymphoma patients who carry multidrug-resistant (MDR) bacteria will progress from harmless colonization to a dangerous active infection. Researchers retrospectively analyzed 70 MDR-positive lymphoma patients treated at a tertiary hospital between 2017 and 2025, finding that nearly 69% ultimately developed an active MDR infection. Through multivariate logistic regression, four independent risk factors were identified: T/NK-cell lymphoma subtype, nasopharyngeal or nasal cavity tumor involvement, recent antibiotic use, and low blood albumin levels below 35 g/L. The team translated these findings into a nomogram — a visual predictive tool — that achieved a C-index of 0.812, indicating strong ability to discriminate between patients likely to develop infection and those who will not. This model offers clinicians a practical, evidence-based instrument for early identification of high-risk lymphoma patients, potentially enabling timely preventive interventions and reducing life-threatening complications from MDR bacterial infections.
Discover oncology
Source →Spinoplastic surgical intervention for the treatment of complex spinal disorders and cancer: An initial cohort of 30 vascularized bone grafts.
Jungbauer WN, et al
Researchers at a single center studied a novel surgical approach called 'spinoplastic' reconstruction, which combines plastic surgery techniques with spine surgery by using vascularized bone grafts (VBGs) to treat complex spinal disorders and cancer-related spinal damage. The study reviewed outcomes from 30 vascularized bone graft procedures performed in 18 patients between October 2022 and November 2024, comparing results against a control group of 18 patients who received non-vascularized bone grafts. The findings showed that VBGs were safe and effective, with no significant differences between groups in hospital stay length, operating time, or blood loss, and nearly 78% of VBG patients reported substantial improvement in pain and function. These results suggest that vascularized bone grafts can be incorporated into complex spinal surgeries without adding meaningful surgical risk or burden, offering a promising tool for plastic surgeons to contribute beyond traditional soft-tissue wound closure. This emerging spinoplastic approach may ultimately improve outcomes for patients facing some of the most challenging spinal reconstruction scenarios, including those caused by cancer.
Journal of plastic, reconstructive & aesthetic surgery : JPRAS
Source →[Effect of 131iodine therapy on parathyroid function in postoperative patients with papillary thyroid carcinoma].
Wu GX, et al
Researchers at the Fourth Hospital of Hebei Medical University investigated whether radioactive iodine-131 (¹³¹I) therapy — a standard post-surgical treatment for papillary thyroid cancer — harms the parathyroid glands, which regulate calcium levels in the blood. The study followed 124 patients who underwent total thyroidectomy without developing parathyroid complications, then received fixed doses of ¹³¹I (100 or 150 mCi) and were monitored for 12 months. Parathyroid hormone (PTH) and serum calcium levels remained stable throughout the follow-up period, with no statistically significant changes at any time point compared to pre-treatment values. Only one patient (0.81%) developed low calcium levels requiring supplementation, and no patient experienced symptomatic hypocalcemia or hypercalcemia. Importantly, parathyroid function was unaffected regardless of ¹³¹I dose, patient sex, age, tumor stage, or extent of lymph node surgery. These findings reassure clinicians that conventional fixed-dose ¹³¹I therapy is safe for parathyroid function in thyroid cancer patients who recover normally from surgery.
Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
Source →